GlaxoSmithKline (GSK) has announced it is to begin searching for a successor to CEO Andrew Witty, who will retire in just over a year's time. Witty has told GSK's board that he intends to retire ...

Since the assassination of his top lieutenant Brian Thompson on Dec. 4, Andrew Witty has been keeping long, difficult hours ...

GlaxoSmithKline’s (GSK) former chief executive Andrew Witty was yesterday announced as the new CEO of Optum – a US payer organisation which includes pharmacy benefits manager OptumRx.

Walmsley, who joined Britain's biggest drugmaker in 2010 from L‘Oreal, will replace Andrew Witty who had previously announced his decision to retire on March 31, 2017. British drugmaker ...

In testimony slated to be delivered before a U.S. House committee, UnitedHealth Group CEO Andrew Witty says that hackers used stolen credentials to log in to a Citrix remote access portal, using ...